FDA Warns Pharmacies

The FDA aims to make an example of seven pharmacies across the nation in a controversy over menopausal hormone therapy.

The pharmacies received warning letters for what the FDA calls illegal use of the non-approved drug component estriol, and false advertising for hormone therapy.

The compounded drug is offered as an alternative therapy to menopausal symptom treatments like Prempro.

The agency says warning letters it delivered to seven pharmacies should be heeded by drug mixers around the country.